Backed by federal
The Belgian government is committed to securing the country’s position as the health and biotech valley of the future, located at the very heart of an ultra-connected Europe.
The R&D bioplatform of the future
In October 2021, the Belgian government under the leadership of Prime Minister De Croo, together with academia and the health and biotech industry, signed a joint charter pledging to further strengthen Belgium's leading position in biopharma R&D and production.
The signing was witnessed by Ursula von der Leyen, President of the European Commission.
Belgium is one of the most welcoming countries in the world, this is an incredibly international environment to do business. We are determined to maintain our unique biotech ecosystem at the heart of a connected Europe based on the top talent we have and a robust set of policies and strategies that we are rolling out right now.
Reinforcing Belgium’s position as the health and biotech valley is really a priority of our government. Belgium has a worldwide reputation in the health sector for more than a century with prime companies and innovative personalities. We want to strengthen the position of the biopharmaceutical sector internationally by attracting talents and bringing innovation and investments to our country. Moreover we are open to new partnerships. In this sector we are clearly punching above our weight and we want to keep it that way.